VILIN BIO

VILIN BIO MED signs 2200cr investment during WEF Davos

VILIN BIO MED signs 2200cr investment during WEF Davos

Switzerland, January 30: Vilin Bio Med Limited, a premier Indian pharmaceutical manufacturer, has marked a historic presence at the 56th Annual Meeting of the World Economic Forum (WEF) in Davos. Led by Managing Director Dr. Madhu Sudhan Reddy Yadamakanti, the company has finalized transformative agreements with the Governments of Maharashtra and Kerala, alongside initiating high-level expansion talks with Qatar. Building India’s Premier Pharma Hub in Maharashtra In a monumental development for the Indian pharmaceutical landscape, Skaah Group Ag, Switzerland—through its SPV Skaah Pharma Ag—signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to establish an Integrated Pharma City…
Read More